Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$963.41
+$35.52 (+3.83%)
Nov 2, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 3.12B | 2.49B | 2.73B | 3.11B | 2.89B | 2.19B |
Short-Term Investments | 5.49B | 6.52B | 8.11B | 4.64B | 2.81B | 1.39B |
Long-Term Investments | 10.26B | 8.9B | 5.4B | 6.59B | 6.84B | 3.14B |
Other Long-Term Assets | 1.82B | 1.14B | 444.1M | 336.4M | 216.1M | 168.1M |
Receivables | 5.74B | 6.21B | 5.67B | 5.33B | 6.04B | 4.11B |
Inventory | 3.2B | 3.09B | 2.58B | 2.4B | 1.95B | 1.92B |
Other Current Assets | 474.8M | 349.2M | 386.6M | n/a | n/a | n/a |
Total Current Assets | 18.02B | 18.66B | 19.48B | 15.88B | 14.01B | 9.78B |
Property-Plant & Equipment | 5.12B | 4.6B | 4.15B | 3.76B | 3.48B | 3.22B |
Goodwill & Intangibles | 1.26B | 1.15B | 1.04B | 915.5M | 6.7M | n/a |
Total Long-Term Assets | 22.54B | 19.1B | 13.6B | 13.33B | 11.42B | 7.38B |
Total Assets | 40.56B | 37.76B | 33.08B | 29.21B | 25.43B | 17.16B |
Account Payables | 939M | 789.5M | 606.6M | 589.2M | 564M | 475.5M |
Deferred Revenue | 553M | 627.7M | 458.9M | 477.9M | 442M | 577.7M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 4.37B | 3.94B | 3.42B | 3.14B | 3.93B | 2.7B |
Long-Term Debt | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B |
Other Long-Term Liabilities | 2.02B | 1.57B | 854.1M | 638M | 680.2M | 687.1M |
Total Long-Term Liabilities | 4.93B | 4.46B | 3.68B | 3.41B | 2.73B | 3.44B |
Total Liabilities | 9.3B | 8.41B | 7.11B | 6.55B | 6.67B | 6.14B |
Total Debt | 2.71B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B |
Book Value | 31.26B | 29.35B | 25.97B | 22.66B | 18.77B | 11.03B |
Book Value Per Share | 287.82 | 255.03 | 228.44 | 199.68 | 167.28 | 95.79 |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 35.8B | 31.67B | 27.26B | 23.31B | 18.97B | 10.89B |
Comprehensive Income | 77.5M | -7.9M | -80.9M | -238.8M | -26.2M | 29.3M |
Shareholders Equity | 31.26B | 29.35B | 25.97B | 22.66B | 18.77B | 11.03B |
Total Investments | 15.75B | 15.42B | 13.51B | 11.23B | 9.65B | 4.53B |
Add to Watchlist
Select watchlists to add or remove REGN